Codexis Announces the Election of New Directors at its Annual Meeting of Stockholders
“We are delighted to welcome these two highly qualified professionals to our board, both of whom bring exceptional experience in biotherapeutics development and commercialization at a time when we are increasing our focus on this business segment,” said
In addition to the election of Drs. Moore and Dilly,
To the extent that statements contained in this press release are not descriptions of historical facts regarding
LHA Investor Relations
Photos accompanying this announcement are available at
Source: Codexis, Inc.